Tokyo, Japan

Yoshitsugu Aoki

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Yoshitsugu Aoki

Introduction

Yoshitsugu Aoki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antisense nucleic acids. With a total of five patents to his name, Aoki's work has the potential to impact medical treatments for genetic disorders.

Latest Patents

Aoki's latest patents include groundbreaking inventions such as an oligomer that allows exon 45 skipping in the human dystrophin gene. This innovation aims to provide therapeutic options for conditions like Duchenne muscular dystrophy. Another notable patent is an antisense nucleic acid that induces skipping of exon 51 in the human dystrophin gene. This specification outlines a drug that facilitates highly efficient skipping of exon 51, showcasing Aoki's commitment to advancing genetic therapies.

Career Highlights

Throughout his career, Aoki has worked with reputable organizations, including Nippon Shinyaku Company, Ltd. and the National Center of Neurology and Psychiatry. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Aoki has collaborated with notable colleagues such as Shin'ichi Takeda and Yukiko Enya. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yoshitsugu Aoki's contributions to the field of biotechnology through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in genetic therapies, making a lasting impact on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…